Corticosteroid Dosing in Patients Receiving Hemodialysis

Pharmacokinetic Considerations

• Hepatic metabolism is the principal route of elimination for corticosteroids, and renal replacement therapy does not significantly alter their clearance; therefore, dialysis has minimal impact on steroid plasma levels. 1, 2

Dosing Recommendations

• No dose adjustment is required for commonly used corticosteroids such as prednisone or methylprednisolone in individuals with end‑stage renal disease or those undergoing hemodialysis. 1, 2
• Standard dosing regimens should be maintained regardless of the timing of dialysis sessions because the quantity removed during a session is clinically insignificant. 1, 2
• A supplemental post‑dialysis dose of corticosteroids is unnecessary, in contrast to drugs that are markedly dialyzable (e.g., aminoglycosides, pyrazinamide). 1, 2, 3

Clinical Monitoring & Peri‑operative Care

• Patients on chronic steroid therapy who develop renal failure and commence dialysis should continue their usual steroid regimen without modification for the dialysis procedure. 4
• The risk of adrenal insufficiency during peri‑operative stress in dialysis patients on chronic steroids requires the same stress‑dose considerations as in non‑dialysis patients. 4

Common Pitfalls to Avoid

• Reducing steroid doses or adding extra doses based on dialysis timing is unnecessary and may lead to under‑treatment of the condition being managed with steroids. 1, 2, 3